Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 10Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Neurotoxicity Syndromes 3Melanoma 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Recurrence 2Ovarian Neoplasms 2Hemorrhage 2Chronic Pain 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Seizures 1Radiodermatitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1

Interventions

Vincristine 1Sodium Chloride 1Prednisone 1Methotrexate 1Lomustine 1Ifosfamide 1Fluoridation 1Etoposide 1Dexmedetomidine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Spinal Cord Neoplasms × Sodium Chloride × Clear all
NCT05493228 2022-08-09

Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

Children's Cancer Hospital Egypt 57357

Phase 3 Unknown
38 enrolled
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡